Answers are grounded in this paper and cite their sources.
Imaging clinical trials can be burdensome and often delay patient access to novel, high-quality medical devices. Tools for in silico imaging trials have significantly improved in sophistication and availability. Here, I describe some of the principal advantages of in silico imaging trials and enumerate five lessons learned during the design and execution of the first all-in silico virtual imaging clinical trial for regulatory evaluation (the VICTRE study).
No takes yet. Share an insight, caveat, or question.
Aldo G. Badano (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: